TY - JOUR
T1 - Predictive power of home blood pressure indices at baseline and during follow-up in hypertensive patients
T2 - HOMED-BP study
AU - on behalf of Hypertension Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP) investigators
AU - Watabe, Daisuke
AU - Asayama, Kei
AU - Hanazawa, Tomohiro
AU - Hosaka, Miki
AU - Satoh, Michihiro
AU - Yasui, Daisaku
AU - Obara, Taku
AU - Inoue, Ryusuke
AU - Metoki, Hirohito
AU - Kikuya, Masahiro
AU - Imai, Yutaka
AU - Ohkubo, Takayoshi
N1 - Funding Information:
Funding This study was funded by grants from the Japan Cardiovascular Research Foundation, the Japan Arteriosclerosis Prevention Fund, and Tohoku University. Fujitsu Systems East Limited (Tokyo, Japan) and Omron Healthcare Co., Ltd. (Kyoto, Japan) developed and maintained the Internet-based infrastructure for the measurement of BP at home and the management of patients. This study was also supported by Grants-in-Aid for Scientific Research (23390171, 25253059, 26860093, 16K15359, and 17H04126) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and Grants-in-Aid for the Japanese Society for the Promotion of Science (JSPS) fellows (25.7756 and 25.9328).
Publisher Copyright:
© 2018, The Japanese Society of Hypertension.
PY - 2018/8/1
Y1 - 2018/8/1
N2 - We compared the predictive power for a major adverse cardiovascular event (MACE) of four home blood pressure (BP) indices (systolic BP, diastolic BP, mean BP, and pulse pressure (PP)) obtained at baseline before treatment and during the on-treatment follow-up period in 3147 patients with essential hypertension (women: 50.1%, mean age: 59.5 years). Associations between MACE and each index were determined using Cox proportional hazard models and the likelihood ratio (LR) test. During a median follow-up of 5.4 years, 46 patients experienced MACE, which was a composite of cardiovascular death, non-fatal stroke, and non-fatal myocardial infarction. The LR test showed that systolic, diastolic, and mean BP during follow-up was more closely associated with cardiovascular risk than the corresponding indices at baseline (LR χ 2 for baseline versus follow-up: systolic BP, (6.0, P = 0.014) versus (11.3, P = 0.0008); diastolic BP, (0.4, P = 0.53) versus (12.4, P = 0.0004); mean BP, (3.2, P = 0.074) versus (15.0, P = 0.0001)), whereas neither PP at baseline nor that during follow-up was significantly associated with MACE risk. Among home BP indices during follow-up, mean BP further improved prediction models in which systolic or diastolic BP was already included (P ≤ 0.042), but neither systolic nor diastolic BP improved models with mean BP (P = 0.80). In addition to home systolic and diastolic BP, mean BP during follow-up period provides essential information in predicting future cardiovascular diseases, whereas its utilization should be further assessed by an intervention trial targeting mean BP levels.
AB - We compared the predictive power for a major adverse cardiovascular event (MACE) of four home blood pressure (BP) indices (systolic BP, diastolic BP, mean BP, and pulse pressure (PP)) obtained at baseline before treatment and during the on-treatment follow-up period in 3147 patients with essential hypertension (women: 50.1%, mean age: 59.5 years). Associations between MACE and each index were determined using Cox proportional hazard models and the likelihood ratio (LR) test. During a median follow-up of 5.4 years, 46 patients experienced MACE, which was a composite of cardiovascular death, non-fatal stroke, and non-fatal myocardial infarction. The LR test showed that systolic, diastolic, and mean BP during follow-up was more closely associated with cardiovascular risk than the corresponding indices at baseline (LR χ 2 for baseline versus follow-up: systolic BP, (6.0, P = 0.014) versus (11.3, P = 0.0008); diastolic BP, (0.4, P = 0.53) versus (12.4, P = 0.0004); mean BP, (3.2, P = 0.074) versus (15.0, P = 0.0001)), whereas neither PP at baseline nor that during follow-up was significantly associated with MACE risk. Among home BP indices during follow-up, mean BP further improved prediction models in which systolic or diastolic BP was already included (P ≤ 0.042), but neither systolic nor diastolic BP improved models with mean BP (P = 0.80). In addition to home systolic and diastolic BP, mean BP during follow-up period provides essential information in predicting future cardiovascular diseases, whereas its utilization should be further assessed by an intervention trial targeting mean BP levels.
UR - http://www.scopus.com/inward/record.url?scp=85047668220&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85047668220&partnerID=8YFLogxK
U2 - 10.1038/s41440-018-0050-4
DO - 10.1038/s41440-018-0050-4
M3 - Article
C2 - 29808033
AN - SCOPUS:85047668220
SN - 0916-9636
VL - 41
SP - 622
EP - 628
JO - Hypertension Research
JF - Hypertension Research
IS - 8
ER -